Evidence map›Paper›PMID 35746469›Full record

ArticleVaccines2022

Co-Administration of Adjuvanted Recombinant

Lisa Luu, Germanus S Bah, Ndode Herman Okah-Nnane, Catherine S Hartley, Alexandra F Glover, Tessa R Walsh, Lu-Yun Lian, Bin Zhan, Maria Elena Bottazzi, David Abraham and 10 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 4 countries.

Lisa LuuInstitute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK.ORCID 0000-0002-7748-5961
Germanus S BahL'Institut de Recherche Agricole Pour le Deéveloppement (IRAD), Yaoundé 2123, Cameroon.ORCID 0000-0003-3231-4250
Ndode Herman Okah-NnaneL'Institut de Recherche Agricole Pour le Deéveloppement (IRAD), Yaoundé 2123, Cameroon.ORCID 0000-0002-7964-9800
Catherine S HartleyInstitute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK.
Alexandra F GloverInstitute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK.
Tessa R WalshInstitute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK.
Lu-Yun LianInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L3 5RF, UK.
Bin ZhanNational School of Tropical Medicine, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0002-6884-9452
Maria Elena BottazziNational School of Tropical Medicine, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0002-8429-0476
David AbrahamDepartment of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Nikolai PetrovskyFlinders Medical Centre, Adelaide 5042, Australia.ORCID 0000-0002-1580-5245
Nicolas BayangL'Institut de Recherche Agricole Pour le Deéveloppement (IRAD), Yaoundé 2123, Cameroon.
Bernard TangwaL'Institut de Recherche Agricole Pour le Deéveloppement (IRAD), Yaoundé 2123, Cameroon.
Rene Billingwe AyisehBiotechnology Unit, University of Buea, Buea P.O. Box 63, Cameroon.ORCID 0000-0001-5308-1666
Glory Enjong MbahDepartment of Biology, Higher Teacher Training College (HTTC), The University of Bamenda, Bambili P.O. Box 39, Cameroon.ORCID 0000-0001-9483-5129
David D EkaleL'Institut de Recherche Agricole Pour le Deéveloppement (IRAD), Yaoundé 2123, Cameroon.
Vincent N TanyaL'Institut de Recherche Agricole Pour le Deéveloppement (IRAD), Yaoundé 2123, Cameroon.
Sara LustigmanMolecular Parasitology, Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10065, USA.ORCID 0000-0003-2389-6113
Benjamin L MakepeaceInstitute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK.ORCID 0000-0002-6100-6727
John Graham-BrownInstitute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK.
University of Liverpool · GBInstitut de Recherche Agricole pour le Développement · CMBaylor College of Medicine · USFlinders Medical Centre · AUNew York Blood Center · USThomas Jefferson University · USUniversity of Bamenda · CMUniversity of Buea · CM

Funding

The development of a recombinant vaccine against human onchocerciasisR01AI078314 · NIAID · NEW YORK BLOOD CENTER · PI LUSTIGMAN, SARA · 2009 to 2021
$7.0M
Novel vaccine adjuvants to counter bioterrorist threatsU01AI061142 · NIAID · FLINDERS UNIVERSITY OF SOUTH AUSTRALIA · PI PETROVSKY, NIKOLAI · 2005 to 2009
$3.5M
NIAID NIH HHS R01 AI078314NIAID NIH HHS U01 AI061142NIH HHS HHS-N272200800039CNIH HHS N272201400053CNIH HHS R01 AI078314NIH HHS U01-AI061142
6 · The paper itself

Abstract

Onchocerciasis (river blindness), caused by the filarial nematode

Indexed as

immunityNTDsonchocerciasisOne Healthriver blindnessvaccine

Identifiers

PMID35746469
PMCPMC9229719
OpenAlexW4281702452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.